{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:24:40Z","timestamp":1648553080577},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.transproceed.2014.11.065","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T09:06:02Z","timestamp":1432976762000},"page":"1110-1113","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival"],"prefix":"10.1016","volume":"47","author":[{"given":"M.A.","family":"Amirzargar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Basiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hajilooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Roshanaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rajabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Solgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.11.065_bib1","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/ki.2010.425","article-title":"Immune monitoring and biomarkers to predict chronic allograft dysfunction","volume":"119","author":"Mannon","year":"2010","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.transproceed.2014.11.065_bib2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.11.065_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOT.0b013e32834ee402","article-title":"Immunologic monitoring in transplantation revisited","volume":"17","author":"Cravedi","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2014.11.065_bib4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.coi.2009.07.014","article-title":"Post-transplant monitoring of renal allografts: are we there yet?","volume":"21","author":"Nickerson","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.transproceed.2014.11.065_bib5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00007890-200004150-00021","article-title":"Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants","volume":"69","author":"S\u00fcsal","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.11.065_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00007890-199901270-00022","article-title":"IgA class antibodies and flow cytometric cross-matching in renal transplantation","volume":"67","author":"Doran","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.11.065_bib7","doi-asserted-by":"crossref","first-page":"S586","DOI":"10.1111\/j.1432-2277.1994.tb01450.x","article-title":"Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival","volume":"7","author":"S\u00fcsal","year":"1994","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2014.11.065_bib8","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/S0041-1345(96)00551-9","article-title":"Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients","volume":"29","author":"S\u00fcsal","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.11.065_bib9","first-page":"1072","article-title":"Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity","volume":"27","author":"S\u00fcsal","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.11.065_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humimm.2013.09.010","article-title":"Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies","volume":"75","author":"Amirzargar","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2014.11.065_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trim.2011.12.002","article-title":"Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA","volume":"26","author":"Solgi","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2014.11.065_bib12","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.transproceed.2009.07.053","article-title":"TH1\/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion","volume":"41","author":"Solgi","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.11.065_bib13","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/01.ASN.0000014256.75920.5B","article-title":"Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30","volume":"13","author":"S\u00fcsal","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2014.11.065_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.transproceed.2011.01.005","article-title":"Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-\u03b21, and interferon-\u03b3 cytokines and expression levels of IL-10 and TGF-\u03b21 genes in renal allograft recipients after donor bone marrow cell infusion","volume":"43","author":"Mohammadnia","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.11.065_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00007890-199601270-00007","article-title":"The impact of elevated serum IgA and race on primary recipient renal allograft survival","volume":"61","author":"Susskind","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.11.065_bib16","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/S0041-1345(98)00896-3","article-title":"Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study","volume":"30","author":"Kim","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.11.065_bib17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.humimm.2007.05.004","article-title":"Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss","volume":"68","author":"Rodr\u00edguez","year":"2007","journal-title":"Hum Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T03:02:58Z","timestamp":1537585378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134515002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0041134515002328"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.11.065","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.11.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}